Last reviewed · How we verify
Continuous Lidocaine Infusion
Continuous Lidocaine Infusion, marketed by Kaohsiung Veterans General Hospital, holds a niche position in the pain management market. The key composition patent expiring in 2028 provides a temporary barrier to generic competition, enhancing its market stability. However, the lack of revenue data and primary trial results poses a significant risk in assessing its long-term commercial viability and therapeutic efficacy.
At a glance
| Generic name | Continuous Lidocaine Infusion |
|---|---|
| Also known as | Lidocaine |
| Sponsor | Kaohsiung Veterans General Hospital. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Lidocaine Infusion Versus Dexmedemidine Infusion on the Neurocognitive Function of Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography(ERCP): a Randomized, Controlled Trial. (NA)
- Effects of Different Drugs for Glottic Atomization on Postoperative Sore Throat After Thyroid Surgery (PHASE4)
- Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy (PHASE4)
- Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
- Intravenous Lidocaine Infusion in Lumbar Fusion Surgery (NA)
- The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery (PHASE4)
- Using Lidocaine or Dexmedetomidine to Help Control Blood Pressure Spikes From a Tourniquet During Knee Surgery (PHASE2)
- Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Continuous Lidocaine Infusion CI brief — competitive landscape report
- Continuous Lidocaine Infusion updates RSS · CI watch RSS
- Kaohsiung Veterans General Hospital. portfolio CI